Shanghai Henlius Biotech, Inc. (HKG:2696)
64.40
-1.55 (-2.35%)
May 28, 2026, 11:50 AM HKT
Shanghai Henlius Biotech Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CICC No rating | CICC | Buy Maintains $102.91 | Buy | Maintains | $102.91 | +59.80% | Apr 24, 2026 |
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains $119.00 | Buy | Maintains | $119.00 | +84.78% | Apr 8, 2026 |
Unknown Analyst Shenwan Hongyuan No rating | Shenwan Hongyuan | Buy Maintains $89.00 | Buy | Maintains | $89.00 | +38.20% | Mar 27, 2026 |
Unknown Analyst SWS Res No rating | SWS Res | Buy Maintains $89.00 | Buy | Maintains | $89.00 | +38.20% | Mar 26, 2026 |
| CMB International Securities | CMB International Securities | Buy Maintains $97.75 → $99.78 | Buy | Maintains | $97.75 → $99.78 | +54.94% | Mar 25, 2026 |
Unknown Analyst Citi No rating | Citi | Buy Maintains $95.00 | Buy | Maintains | $95.00 | +47.52% | Mar 23, 2026 |